Vincenzo Alessandro Gennarino
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Vincenzo Alessandro Gennarino has a total of 333 co-authors. Here are the top co-authors by number of shared publications:
- Huda Yahya Zoghbi
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX
8 shared publications - Sandro Banfi
Department of Precision Medicine, Medical Genetics, University of Campania ‘Luigi Vanvitelli’, Naples, Italy
8 shared publications Nicola de Prisco
Department of Genetics and Development, Columbia University Irving Medical Center, New York, NY, USA
6 shared publicationsAlexei Chemiakine
Department of Genetics and Development, Columbia University Irving Medical Center, New York, NY, USA
5 shared publicationsSalvatore Botta
Department of Genetics and Development, Columbia University Irving Medical Center, New York, NY, USA
4 shared publicationsWinston Lee
Department of Genetics and Development, Columbia University Irving Medical Center, New York, NY, USA
4 shared publications
Latest Publications
- Open Access
- 28 August 2025
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 135 (21)
Corrigendum to CERT1 mutations perturb human development by disrupting sphingolipid homeostasis
- 28 August 2025
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 135 (21)
Open AccessCorrigendum to CERT1 mutations perturb human development by disrupting sphingolipid homeostasis
- Open Access
- 13 August 2025
- Published by Elsevier in Cell Reports
- Vol. 44 (8) , 116145
Alpha-synuclein abundance and localization are regulated by the RNA-binding protein PUMILIO1
- 13 August 2025
- Published by Elsevier in Cell Reports
- Vol. 44 (8) , 116145
Open AccessAlpha-synuclein abundance and localization are regulated by the RNA-binding protein PUMILIO1
- Open Access
The retrotransposon - derived capsid genes PNMA1 and PNMA4 maintain reproductive capacity
The human genome contains 24 gag -like capsid genes derived from deactivated retrotransposons conserved among eutherians. Although some of their encoded proteins retain the ability to form capsids and even transfer cargo, their fitness benefit has remained elusive. Here we show that the gag -like genes PNMA1 and PNMA4 support reproductive capacity. Six-week-old mice lacking either Pnma1 or Pnma4 are indistinguishable from wild-type littermates, but by six months the mutant mice become prematurely subfertile, with precipitous drops in sex hormone levels, gonadal atrophy, and abdominal obesity; overall they produce markedly fewer offspring than controls. Analysis of donated human ovaries shows that expression of both genes declines normally with aging, while several PNMA1 and PNMA4 variants identified in genome-wide association studies are causally associated with low testosterone, altered puberty onset, or obesity. These findings expand our understanding of factors that maintain human reproductive health and lend insight into the domestication of retrotransposon-derived genes.
Open AccessThe retrotransposon - derived capsid genes PNMA1 and PNMA4 maintain reproductive capacity
The human genome contains 24 gag -like capsid genes derived from deactivated retrotransposons conserved among eutherians. Although some of their encoded proteins retain the ability to form capsids and even transfer cargo, their fitness benefit has remained elusive. Here we show that the gag -like genes PNMA1 and PNMA4 support reproductive capacity. Six-week-old mice lacking either Pnma1 or Pnma4 are indistinguishable from wild-type littermates, but by six months the mutant mice become prematurely subfertile, with precipitous drops in sex hormone levels, gonadal atrophy, and abdominal obesity; overall they produce markedly fewer offspring than controls. Analysis of donated human ovaries shows that expression of both genes declines normally with aging, while several PNMA1 and PNMA4 variants identified in genome-wide association studies are causally associated with low testosterone, altered puberty onset, or obesity. These findings expand our understanding of factors that maintain human reproductive health and lend insight into the domestication of retrotransposon-derived genes.
- Open Access
- 15 May 2023
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 133 (10)
CERT1 mutations perturb human development by disrupting sphingolipid homeostasis
Neural differentiation, synaptic transmission, and action potential propagation depend on membrane sphingolipids, whose metabolism is tightly regulated. Mutations in the ceramide transporter CERT (CERT1), which is involved in sphingolipid biosynthesis, are associated with intellectual disability, but the pathogenic mechanism remains obscure. Here, we characterize 31 individuals with de novo missense variants in CERT1. Several variants fall into a previously uncharacterized dimeric helical domain that enables CERT homeostatic inactivation, without which sphingolipid production goes unchecked. The clinical severity reflects the degree to which CERT autoregulation is disrupted, and inhibiting CERT pharmacologically corrects morphological and motor abnormalities in a Drosophila model of the disease, which we call ceramide transporter (CerTra) syndrome. These findings uncover a central role for CERT autoregulation in the control of sphingolipid biosynthetic flux, provide unexpected insight into the structural organization of CERT, and suggest a possible therapeutic approach for patients with CerTra syndrome.
- 15 May 2023
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 133 (10)
Open AccessCERT1 mutations perturb human development by disrupting sphingolipid homeostasis
Neural differentiation, synaptic transmission, and action potential propagation depend on membrane sphingolipids, whose metabolism is tightly regulated. Mutations in the ceramide transporter CERT (CERT1), which is involved in sphingolipid biosynthesis, are associated with intellectual disability, but the pathogenic mechanism remains obscure. Here, we characterize 31 individuals with de novo missense variants in CERT1. Several variants fall into a previously uncharacterized dimeric helical domain that enables CERT homeostatic inactivation, without which sphingolipid production goes unchecked. The clinical severity reflects the degree to which CERT autoregulation is disrupted, and inhibiting CERT pharmacologically corrects morphological and motor abnormalities in a Drosophila model of the disease, which we call ceramide transporter (CerTra) syndrome. These findings uncover a central role for CERT autoregulation in the control of sphingolipid biosynthetic flux, provide unexpected insight into the structural organization of CERT, and suggest a possible therapeutic approach for patients with CerTra syndrome.
- Open Access
- 18 April 2023
- Published by Springer Nature in The EMBO Journal
- Vol. 42 (11) , e112721
Dosage sensitivity to Pumilio1 variants in the mouse brain reflects distinct molecular mechanisms
Different mutations in the RNA‐binding protein Pumilio1 (PUM1) cause divergent phenotypes whose severity tracks with dosage: a mutation that reduces PUM1 levels by 25% causes late‐onset ataxia, whereas haploinsufficiency causes developmental delay and seizures. Yet PUM1 targets are derepressed to equal degrees in both cases, and the more severe mutation does not hinder PUM1's RNA‐binding ability. We therefore considered the possibility that the severe mutation might disrupt PUM1 interactions, and identified PUM1 interactors in the murine brain. We find that mild PUM1 loss derepresses PUM1‐specific targets, but the severe mutation disrupts interactions with several RNA‐binding proteins and the regulation of their targets. In patient‐derived cell lines, restoring PUM1 levels restores these interactors and their targets to normal levels. Our results demonstrate that dosage sensitivity does not always signify a linear relationship with protein abundance but can involve distinct mechanisms. We propose that to understand the functions of RNA‐binding proteins in a physiological context will require studying their interactions as well as their targets.
- 18 April 2023
- Published by Springer Nature in The EMBO Journal
- Vol. 42 (11) , e112721
Open AccessDosage sensitivity to Pumilio1 variants in the mouse brain reflects distinct molecular mechanisms
Different mutations in the RNA‐binding protein Pumilio1 (PUM1) cause divergent phenotypes whose severity tracks with dosage: a mutation that reduces PUM1 levels by 25% causes late‐onset ataxia, whereas haploinsufficiency causes developmental delay and seizures. Yet PUM1 targets are derepressed to equal degrees in both cases, and the more severe mutation does not hinder PUM1's RNA‐binding ability. We therefore considered the possibility that the severe mutation might disrupt PUM1 interactions, and identified PUM1 interactors in the murine brain. We find that mild PUM1 loss derepresses PUM1‐specific targets, but the severe mutation disrupts interactions with several RNA‐binding proteins and the regulation of their targets. In patient‐derived cell lines, restoring PUM1 levels restores these interactors and their targets to normal levels. Our results demonstrate that dosage sensitivity does not always signify a linear relationship with protein abundance but can involve distinct mechanisms. We propose that to understand the functions of RNA‐binding proteins in a physiological context will require studying their interactions as well as their targets.
- 17 February 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (7) , eade4814
Alternative polyadenylation alters protein dosage by switching between intronic and 3′UTR sites
Alternative polyadenylation (APA) creates distinct transcripts from the same gene by cleaving the pre-mRNA at poly(A) sites that can lie within the 3′ untranslated region (3′UTR), introns, or exons. Most studies focus on APA within the 3′UTR; however, here, we show that CPSF6 insufficiency alters protein levels and causes a developmental syndrome by deregulating APA throughout the transcript. In neonatal humans and zebrafish larvae, CPSF6 insufficiency shifts poly(A) site usage between the 3′UTR and internal sites in a pathway-specific manner. Genes associated with neuronal function undergo mostly intronic APA, reducing their expression, while genes associated with heart and skeletal function mostly undergo 3′UTR APA and are up-regulated. This suggests that, under healthy conditions, cells toggle between internal and 3′UTR APA to modulate protein expression.
- 17 February 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (7) , eade4814
Alternative polyadenylation alters protein dosage by switching between intronic and 3′UTR sites
Alternative polyadenylation (APA) creates distinct transcripts from the same gene by cleaving the pre-mRNA at poly(A) sites that can lie within the 3′ untranslated region (3′UTR), introns, or exons. Most studies focus on APA within the 3′UTR; however, here, we show that CPSF6 insufficiency alters protein levels and causes a developmental syndrome by deregulating APA throughout the transcript. In neonatal humans and zebrafish larvae, CPSF6 insufficiency shifts poly(A) site usage between the 3′UTR and internal sites in a pathway-specific manner. Genes associated with neuronal function undergo mostly intronic APA, reducing their expression, while genes associated with heart and skeletal function mostly undergo 3′UTR APA and are up-regulated. This suggests that, under healthy conditions, cells toggle between internal and 3′UTR APA to modulate protein expression.
- Open Access
- 10 June 2022
- Published by Elsevier in STAR Protocols
- Vol. 3 (2) , 101427
Dual antibody strategy for high-resolution imaging of murine Purkinje cells and their dendrites across multiple layers
- 10 June 2022
- Published by Elsevier in STAR Protocols
- Vol. 3 (2) , 101427
Open AccessDual antibody strategy for high-resolution imaging of murine Purkinje cells and their dendrites across multiple layers
- Open Access
- 15 March 2022
- Published by Elsevier in STAR Protocols
- Vol. 3 (2) , 101232
Determining the effects of loss of function mutations in human cell lines
- 15 March 2022
- Published by Elsevier in STAR Protocols
- Vol. 3 (2) , 101232
Open AccessDetermining the effects of loss of function mutations in human cell lines
- Open Access
- 15 March 2022
- Published by Elsevier in STAR Protocols
- Vol. 3 (2) , 101244
Protocol to assess the effect of disease-driving variants on mouse brain morphology and primary hippocampal neurons
- 15 March 2022
- Published by Elsevier in STAR Protocols
- Vol. 3 (2) , 101244
Open AccessProtocol to assess the effect of disease-driving variants on mouse brain morphology and primary hippocampal neurons
- Open Access
- 14 March 2022
- Published by Elsevier in STAR Protocols
- Vol. 3 (2) , 101245
Protocol for recording epileptiform discharges of EEG and behavioral seizures in freely moving mice
- 14 March 2022
- Published by Elsevier in STAR Protocols
- Vol. 3 (2) , 101245
Open AccessProtocol for recording epileptiform discharges of EEG and behavioral seizures in freely moving mice